Old Second National Bank of Aurora’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,853
| Closed | -$1.81M | – | 316 |
|
|
2025
Q1 | $1.81M | Buy |
2,853
+10
| +0.4% | +$6.88K | 0.43% | 67 |
|
|
2024
Q4 | $2.03M | Buy |
2,843
+15
| +0.5% | +$12.6K | 0.46% | 62 |
|
|
2024
Q3 | $2.97M | Sell |
2,828
-66
| -2% | -$73.4K | 0.72% | 43 |
|
|
2024
Q2 | $3.04M | Sell |
2,894
-104
| -3% | -$101K | 0.78% | 39 |
|
|
2024
Q1 | $2.89M | Sell |
2,998
-53
| -2% | -$50.4K | 0.75% | 41 |
|
|
2023
Q4 | $2.68M | Sell |
3,051
-14
| -0.5% | -$11.5K | 0.74% | 45 |
|
|
2023
Q3 | $2.52M | Sell |
3,065
-127
| -4% | -$99.8K | 0.77% | 44 |
|
|
2023
Q2 | $2.29M | Sell |
3,192
-143
| -4% | -$110K | 0.66% | 50 |
|
|
2023
Q1 | $2.74M | Sell |
3,335
-264
| -7% | -$199K | 0.8% | 42 |
|
|
2022
Q4 | $2.6M | Sell |
3,599
-41
| -1% | -$30.3K | 0.77% | 47 |
|
|
2022
Q3 | $2.51M | Sell |
3,640
-46
| -1% | -$29K | 0.77% | 46 |
|
|
2022
Q2 | $2.18M | Sell |
3,686
-758
| -17% | -$493K | 0.61% | 60 |
|
|
2022
Q1 | $3.1M | Buy |
+4,444
| New | +$2.81M | 0.78% | 40 |
|
|
2021
Q4 | – | Sell |
-4,309
| Closed | -$2.61M | – | 357 |
|
|
2021
Q3 | $2.61M | Buy |
+4,309
| New | +$2.68M | 0.7% | 55 |
|
|
2020
Q1 | – | Sell |
-139
| Closed | -$52K | – | 354 |
|
|
2019
Q4 | $52K | Hold |
139
| – | – | 0.02% | 200 |
|
|
2019
Q3 | $39K | Hold |
139
| – | – | 0.01% | 204 |
|
|
2019
Q2 | $44K | Hold |
139
| – | – | 0.02% | 204 |
|
|
2019
Q1 | $57K | Hold |
139
| – | – | 0.02% | 192 |
|
|
2018
Q4 | $52K | Hold |
139
| – | – | 0.02% | 195 |
|
|
2018
Q3 | $56K | Hold |
139
| – | – | 0.02% | 194 |
|
|
2018
Q2 | $48K | Hold |
139
| – | – | 0.02% | 205 |
|
|
2018
Q1 | $48K | Buy |
+139
| New | +$48.3K | 0.02% | 194 |
|
|
2017
Q4 | – | Sell |
-66
| Closed | -$30K | – | 372 |
|
|
2017
Q3 | $30K | Hold |
66
| – | – | 0.01% | 225 |
|
|
2017
Q2 | $32K | Hold |
66
| – | – | 0.01% | 212 |
|
|
2017
Q1 | $26K | Hold |
66
| – | – | 0.01% | 227 |
|
|
2016
Q4 | $24K | Buy |
+66
| New | +$25.1K | 0.01% | 240 |
|
|
2016
Q2 | – | Sell |
-15
| Closed | -$5K | – | 331 |
|
|
2016
Q1 | $5K | Sell |
15
-15
| -50% | -$6.18K | ﹤0.01% | 289 |
|
|
2015
Q4 | $16K | Hold |
30
| – | – | 0.01% | 237 |
|
|
2015
Q3 | $14K | Hold |
30
| – | – | 0.01% | 251 |
|
|
2015
Q2 | $15K | Hold |
30
| – | – | 0.01% | 251 |
|
|
2015
Q1 | $14K | Buy |
+30
| New | +$12.7K | 0.01% | 256 |
|
Other funds holding REGN
Old Second National Bank of Aurora's REGN Position: Q2 2025 in Review
Old Second National Bank of Aurora sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 2,853 shares — an estimated $1.81M sold.
Old Second National Bank of Aurora first reported a position in REGN in Q1 2015 and held it in 31 quarters. The position peaked at $3.1M in Q1 2022. 1,203 funds tracked by Wall St. Rank hold REGN as of Q2 2025.
- Old Second National Bank of Aurora reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Old Second National Bank of Aurora sold 2,853 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $1.81M.
- Old Second National Bank of Aurora first reported a position in Regeneron Pharmaceuticals in Q1 2015 and held it in 31 quarters.
- Old Second National Bank of Aurora's Regeneron Pharmaceuticals position peaked at $3.1M in Q1 2022.
- 1,203 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.
Based on Old Second National Bank of Aurora's 13F filing for Q2 2025, filed 21 Jul 2025.